Chromosome 7 deletion present at diagnosis in Ph1 negative CML

Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL.

Leukemia & lymphoma·2016

Two Translocations: a Follicular Variant 2; 18 and a Burkitt 8;14 in a Small Non Cleaved Non Hodgkin's Lymphoma.

Leukemia & lymphoma·2016

CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.

Leukemia·2011

Breakpoints of 11q25 in three similar cases of B non Hodgkin's lymphoma.

Leukemia & lymphoma·2011

Chromosome 1p abnormalities in B non Hodgkin's lymphoma.

Leukemia & lymphoma·2011

Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction.

Journal of endocrinological investigation·2008

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Haematologica·2026

Identification of the Novel HLA-A*68:346 Allele in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026

Immunoglobulin Superfamily Protein BTNL9 Functions as a Non-Canonical Transcriptional Regulator to Suppress NSCLC Through Cell Cycle and p53 Pathways.

International journal of molecular sciences·2026

Identification of the Novel HLA-DRB1*04:01:26 Allele by Next-Generation Sequencing.

HLA·2026

The HLA-C*08:01:45 Allele, Identified by Next-Generation Sequencing in an Indian Individual.

HLA·2026

Identification of the Novel HLA-DRB1*11:01:49 Allele Using Next-Generation Sequencing in a Chinese Individual.

HLA·2026

Resolving diagnostic complexity: long-read sequencing unmasks a Hong Kongαα/‒α4.2 genotype mimicking a heterozygous ‒α3.7 deletion on multiplex ligation-dependent probe amplification.

Laboratory medicine·2026

Related Experiment Videos

Chromosome 7 deletion present at diagnosis in Ph1 negative CML

Related Concept Videos

Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL.

Two Translocations: a Follicular Variant 2; 18 and a Burkitt 8;14 in a Small Non Cleaved Non Hodgkin's Lymphoma.

CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.

Breakpoints of 11q25 in three similar cases of B non Hodgkin's lymphoma.

Chromosome 1p abnormalities in B non Hodgkin's lymphoma.

Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Identification of the Novel HLA-A*68:346 Allele in a Brazilian Individual by Next-Generation Sequencing.

Immunoglobulin Superfamily Protein BTNL9 Functions as a Non-Canonical Transcriptional Regulator to Suppress NSCLC Through Cell Cycle and p53 Pathways.

Identification of the Novel HLA-DRB1*04:01:26 Allele by Next-Generation Sequencing.

The HLA-C*08:01:45 Allele, Identified by Next-Generation Sequencing in an Indian Individual.

Identification of the Novel HLA-DRB1*11:01:49 Allele Using Next-Generation Sequencing in a Chinese Individual.

Resolving diagnostic complexity: long-read sequencing unmasks a Hong Kongαα/‒α4.2 genotype mimicking a heterozygous ‒α3.7 deletion on multiplex ligation-dependent probe amplification.

Related Experiment Videos

Chromosome 7 deletion present at diagnosis in Ph1 negative CML

Related Concept Videos

Related Articles